Bionaut Labs was founded in 2016 with a vision to revolutionize the treatment of central nervous system disorders with its Bionaut™ precision medicine treatment modality that uses remote-controlled microscale robots to deliver biologics, nucleic acids, or small molecule therapies locally to targeted disease areas. Bionaut Labs’ headquarters is in Los Angeles, California, with additional R&D sites in Israel and at the Max Planck Institute in Germany.